In-depth valuation analysis including DCF scenarios and peer comparisons.
AI Insight: The Procter & Gamble stock trades 18.5% below its PERT-weighted fair value of $176.85, indicating potential undervaluation supported by strong DCF and analyst target estimates. High profitability and efficiency scores contrast with moderate liquidity and growth, suggesting stable earnings but limited expansion. Monte Carlo analysis reveals high volatility and a 44.1% downside risk, reflecting notable valuation uncertainty despite a favorable median outcome.